BETA DRUGS
Back to Income Statement
|
BETA DRUGS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹42 Cr | ₹36 Cr | ₹31 Cr | ₹25 Cr | ₹12 Cr |
What is the latest Consolidated Net Profit of BETA DRUGS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹42 Cr |
| Mar2024 | ₹36 Cr |
| Mar2023 | ₹31 Cr |
| Mar2022 | ₹25 Cr |
| Mar2021 | ₹12 Cr |
How is Consolidated Net Profit of BETA DRUGS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹42 Cr | 16.42 | |
| Mar2024 | ₹36 Cr | 18.61 | |
| Mar2023 | ₹31 Cr | 23.73 | |
| Mar2022 | ₹25 Cr | 111.75 | |
| Mar2021 | ₹12 Cr | - | |
Compare Consolidated Net Profit of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,606.1 Cr | 13.5% | 59.1% | 35.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,644.0 Cr | 1.1% | 7.2% | 15.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹184,053.0 Cr | 2.4% | 4.2% | -1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹167,464.0 Cr | 1.9% | 8.3% | 45.6% | Stock Analytics | |
| CIPLA | ₹115,263.0 Cr | -1.8% | 3.2% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,049.0 Cr | -8.8% | -3.2% | -4.6% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 13.5% |
59.1% |
35.7% |
| SENSEX | -0.9% |
4.9% |
-6.8% |
You may also like the below Video Courses